Browsing Tag
Anteris Technologies Global Corp.
2 posts
Anteris edges closer to FDA IDE approval for DurAVR PARADIGM trial after promising clinical data
Find out how Anteris’s DurAVR transcatheter heart valve is advancing toward a global pivotal trial and what it means for the structural heart market.
Anteris Technologies launches its pivotal trial phase for DurAVR THV, marking a regulatory turning point
Anteris Technologies launches the global PARADIGM pivotal trial of its DurAVR THV, challenging Edwards and Medtronic with biomimetic valve durability data—see how the race unfolds.